Icon of the Instituts for Quality and Efficiency in Health Care

Report

Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

Status
Status: Commission completed
Project no.
A08-01
Last updated

Report documents

  1. Executive summary of the final report

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 56 kB, EN, not accessible
    Download file : Executive summary of the final report (PDF document, 56 kB, EN, not accessible)

  2. Final report

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    Download file : Final report (PDF document, 1 MB, DE, not accessible)

  3. Documentation and appraisal of comments on the preliminary report

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the preliminary report (PDF document, 2 MB, DE, not accessible)

  4. Executive summary of the preliminary report

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 157 kB, DE, not accessible
    Download file : Executive summary of the preliminary report (PDF document, 157 kB, DE, not accessible)

  5. Preliminary report

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 786 kB, DE, not accessible
    Download file : Preliminary report (PDF document, 786 kB, DE, not accessible)

  6. Report plan version 1.0

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 202 kB, DE, not accessible
    Download file : Report plan version 1.0 (PDF document, 202 kB, DE, not accessible)

  7. Documentation and appraisal of comments on the report plan (preliminary version)

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the report plan (preliminary version) (PDF document, 2 MB, DE, not accessible)

  8. Report plan - preliminary version

    Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1 - follow-up commission

    published on
    Document type
    PDF document, 124 kB, DE, not accessible
    Download file : Report plan - preliminary version (PDF document, 124 kB, DE, not accessible)

Press releases

Rapid-acting insulin analogues: Trials provide no proof of additional benefit for children and adolescents with type 1 diabetes

Long-term research is lacking – potential harm remains unclear – valid studies are urgently needed for growing and developing children and adolescents
Press release

Additional information

IQWiG health information

Types of insulin

Project details

Project no.
A08-01
Commission
Commission awarded on 17.07.2008 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Digestion, metabolism and hormones

Connected Projects

  1. Report

    Rapid-acting insulin analogues in the treatment of diabetes mellitus type 1

    Project no.
    A05-02
    Last updated

    Status: Commission completed

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page